Bookmark

Add to MyYahoo RSS

Cytosar-U, Cytarabine News

News on Cytosar-U, Cytarabine (generic) continually updated from thousands of sources around the net.

Thursday Jul 24 | Hispanic Business

Synta Announces Ganetespib Into Phase 3 Extension Of Aml Li-1 Study;...

AML LI-1 is a multicenter, randomized Phase 2/3 clinical study evaluating several novel treatment regimens, including the combination of ganetespib with low dose cytarabine , in newly diagnosed elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who are not eligible for intensive chemotherapy.

Comment?

Related Topix: Medicine, Family, Elderly (Senior Citizen)

Mon Jul 21, 2014

Theflyonthewall.com

Synta Pharmaceuticals advances ganetespib into Phase 3 extension of Aml Li-1

Synta Pharmaceuticals advances ganetespib into Phase 3 extension of AML LI-1 Synta Pharmaceuticals announced the advancement of ganetespib into the Phase 3 extension of the AML LI-1 trial.

Comment?

Related Topix: Synta Pharmaceuticals, Biotech, Medicine, Healthcare Industry

Thu Jul 17, 2014

Hispanic Business

Celator(R) Pharmaceuticals Provides Update on CPX-351 and Technology Platform at Analyst Day

"We are very excited to announce that we are broadening the application of the CombiPlex platform and expect to advance the technology to include molecularly targeted therapies in 2015," said .

Comment?

Related Topix: Daunorubicin (generic), DaunoXome, Medicine

•••
•••
•••
•••
•••
•••
•••